Anastatins A and B, new skeletal flavonoids with hepatoprotective activities from the desert plant Anastatica hierochuntica

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 6, 2003, Pages 1045-1049

  Yoshikawa, Masayuki ^a   Xu, Fengming ^a   Morikawa, Toshio ^a   Ninomiya, Kiyofumi ^a   Matsuda, Hisashi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3' O METHYLTAXIFOLIN; ANASTATICA HIEROCHUNTICA EXTRACT; ANASTATIN A; ANASTATIN B; AROMADENDRIN; BENZOFURAN DERIVATIVE; EPITAXIFOLIN; ERIODICTYOL; FLAVANONE DERIVATIVE; FLAVONOID; GALACTOSAMINE; LIVER PROTECTIVE AGENT; METHANOL; NARINGENIN; PLANT EXTRACT; SILIBININ; TAXIFOLIN; UNCLASSIFIED DRUG;

ANASTATICA HIEROCHUNTICA; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG ISOLATION; DRUG STRUCTURE; LIVER CELL CULTURE; LIVER PROTECTION; MEDICINAL PLANT; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY;

ANASTATICA; ANASTATICA HIEROCHUNTICA;

EID: 0037463804     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00088-X     Document Type: Article

References (25)

1. (a) Rizk A.M., Hammouda F.M., Ismail S.I., Hassan N.M., Ahmed F.A. Int. J. Pharmacog. 31:1993;327
2. (b) Abou-Mandour A., Hartung W. Plant Cell Reports. 14:1995;657.
3. (a) Yoshikawa M., Murakami T., Kishi A., Kageura T., Matsuda H. Chem. Pharm. Bull. 49:2001;863
4. (b) Murakami T., Kishi A., Yoshikawa M. Chem. Pharm. Bull. 49:2001;974
5. (c) Morikawa T., Xu F., Matsuda H., Yoshikawa M. Heterocycles. 57:2002;1983.
6. (a) Matsuda H., Morikawa T., Ninomiya K., Yoshikawa M. Bioorg. Med. Chem. 9:2001;909
7. (b) Murakami T., Kohno K., Ninomiya K., Yoshikawa M. Chem. Pharm. Bull. 49:2001;1003
8. (c) Matsuda H., Ninomiya K., Shimoda H., Yoshikawa M. Bioorg. Med. Chem. 10:2002;707
9. (d) Morikawa T., Matsuda H., Ninomiya K., Yoshikawa M. Biol. Pharm. Bull. 25:2002;627.
10. Niwa M., Otsuji S., Tatematsu H., Liu G., Chen X., Hirata Y. Chem. Pharm. Bull. 34:1986;3249.
11. 5b
12. (b) Matsuda H., Morikawa T., Toguchida I., Harima S., Yoshikawa M. Chem. Pharm. Bull. 50:2002;972.
13. Bellakhdar J., Passannanti S., Paternostro M.P., Piozzi F. Planta Med. 54:1988;94.
14. Nonaka G., Goto Y., Kinjo J., Nohara T., Nishioka I. Chem. Pharm. Bull. 35:1987;1105.
15. Marco J.A., Sanz-Cervera J.F., Yuste A., Oriola M.C. Phytochemistry. 36:1994;725.
16. (a) Matsuda H., Morikawa T., Toguchida I., Yoshikawa M. Chem. Pharm. Bull. 50:2002;788
17. (b) Matsuda H., Morikawa T., Ueda K., Managi H., Yoshikawa M. Bioorg. Med. Chem. 10:2002;3123.
18. From the EtOAc-soluble fraction, 11 aromatic compounds; p-hydroxybenzoic acid (0.0012%), p-methoxybenzoic acid (0.00075%), 3,4-dihydroxybenzoic acid (0.0025%), 3-methoxy-4-hydroxybenzoic acid (0.0068%), p-hydroxybenzaldehyde (0.00093%), 3,4-dihydroxybenzaldehyde (0.0016%), vanillin (0.0036%), acetovanillone (0.00066%), 2,4′-dihydroxy-3′-methoxyacetophenone (0.0011%), ω-hydroxypropioguaiacone (0.0015%), and (+)-2,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)-1-propanone (0.0015%), three phenylpropanoids; trans-cinnamic acid (0.00059%), trans-ferulic acid (0.00079%), and coniferaldehyde (0.0013%), 12 lignans; 1,2-bis-(4-hydroxy-3-methoxyphenyl)-propane-1,3-diols [erythro form (0.0029%) and threo form (0.0011%)], evofolin B (0.00093%), (+)-isolariciresinol (0.0013%), (+)-pinoresinol (0.00047%), ficusal (0.0011%), balanophonin (0.00045%), (+)-dehydrodiconiferyl alcohol (0.0011%), 2,3-dihydro-2-(3,4-dimethoxyphenyl)-3-hydroxymethyl-5-(2-formylvinyl)-7- hydroxybenzofuran (0.0061%), 4-[2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-(hydroxymethyl)ethoxy]-3- methoxybenzaldehyde (0.00060%), 1-(4-hydroxy-3-methoxyphenyl)-2-{4-[2-formyl-(E)-vinyl]-2-methoxyphenoxy}- propane-1,3-diol(0.00019%) and 3-hydroxy-1-{4-[2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-(hydroxymethyl) ethoxy]-3-methoxyphenyl}-1-propanone (0.00024%) and 4 flavonolignans; (+)- and (-)-silychristins [(0.0011%), (0.00073%)], silybin (0.0025%), and isosilybin (0.0024%) were isolated.
19. 6, 9).
20. 1H COSY), distortionless enhancement by polarization transfer (DEPT), and heteronuclear multiple bond connectivity (HMBC) experiments.
21. Gaffield W. Tetrahedron. 26:1970;4093.
22. -1.
23. 6, 10).
24. (a) Feher J., Deak G., Muzes G., Lang I., Niederland V., Nekam K., Karteszi M. Orv. Hetil. 130:1989;2723
25. (b) Skottova N., Krecman V. Physiol. Res. 47:1998;1.